PipelineReview.com La Merie, S.L.
Categories
Biotech & generics
Business & market
Cardiovascular & blood
Company Profiles
Dermatology
Diagnostics & biomarkers
Gastrointestinal
Genitourinary & gynecology
Healthcare
Infectious & toxicology
Medical devices
Medical Equipment
Metabolism & endocrine
Metabolism& endocrine
Neurology & psychiatry
Oncology
Ophthalmology & otorhino
Orthopedics & anesthesia
Pulmonary & respiratory
Research & Development
Rheumatoid & autoimmune
Target pipeline
Technologies
Periodicals
Publishers
BioSeeker Group
Business Insights
Business Monitor International
Datamonitor
Espicom
FirstWord Reports
GBI Research
GlobalData
Insight Pharma Reports
Jain PharmaBiotech
Kalorama Information
La Merie Publishing
Life Science Analytics
MarketsandMarkets
Scientia Veritas
Visiongain
Product Lines
Analytical Tool
Brief Report
Commercial & Pipeline Insight
Commercial & Pipeline Perspective
Commercial Insight
Competitor Analysis
Database
Drug Pipeline Report
Drug Pipeline Update
Drug Profile
Emerging Company Profile
Financial Deals Industry Tracker
Full Report
Insight Pharma
PharmaVitae Profile
Pipeline Insight
Pipeline/Commercial Insight
Premium Company Profile
Self-Service Products
Stakeholder Insight
Stakeholder Opinions
Triple Analysis
Pipeline Review Online Store - Biotech Reports by La Merie, Datamomitor, Business Insight, Kalorama, Life Science Analytics, Visiongain and Sciencia Veritas.
Reports on biopharmaceutical R&D provide competitive information and in-depth analysis from publishers La Merie, Datamomitor, Business Insight, Kalorama, Life Science Analytics, Visiongain, andSciencia Veritas. Secure Online payment with credit card and download or mail delivery of the report in PDF format.
Featured Products
Pharmaceutical Company Outlook to 20146,069  EUR
[$7,600.00 USD]
Benchmarking the Pharmaceutical Market by Drug Delivery to 20146,069  EUR
[$7,600.00 USD]
Pipeline Insight: Biologic Targeted Cancer Therapies - Next generation jostles for market position9,103  EUR
[$11,400.00 USD]
New Products For May
Anesthesia Drugs Market (2011 - 2015) - U.S. Market Entry Study3,713  EUR
[$4,650.00 USD]
Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 20193,190  EUR
[$3,995.00 USD]
Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth2,795  EUR
[$3,500.00 USD]
Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation2,795  EUR
[$3,500.00 USD]
Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion2,795  EUR
[$3,500.00 USD]
Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules2,795  EUR
[$3,500.00 USD]
Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments2,795  EUR
[$3,500.00 USD]
Chronic Kidney Disease (CKD) Therapeutics - Pipeline Assessment and Market Forecasts to 20182,515  EUR
[$3,150.00 USD]
Backup Compound Strategies: Commercial and Tactical Considerations1,992  EUR
[$2,495.00 USD]

 Upcoming Products   Date Expected 
 Triple Analysis: Angiogenesis, Protein Kinase Inhibitors and Peptides   05/30/2012 
 Triple Analysis: Pancreatic Cancer, Prostate Cancer and Protein Kinase Inhibitors   05/30/2012 
 Triple Analysis: Pancreatic Cancer, Apoptosis and Protein Kinase Inhibitors   05/30/2012 
 Triple Analysis: Pancreatic Cancer, Angiogenesis and Protein Kinase Inhibitors   05/30/2012 
 Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Protein Kinase Inhibitors   05/30/2012 
 Triple Analysis: Pancreatic Cancer, Protein Kinase Inhibitors and Antibodies   05/30/2012 
 Triple Analysis: Pancreatic Cancer, Protein Kinase Inhibitors and Peptides   05/30/2012 
 Triple Analysis: Prostate Cancer, Apoptosis and Angiogenesis   05/30/2012 
 Triple Analysis: Prostate Cancer, Angiogenesis and Cancer Vaccines   05/30/2012 
 Triple Analysis: Prostate Cancer, Angiogenesis and Protein Kinase Inhibitors   05/30/2012 
Currencies
Shopping Cart more
0 items
Quick Find
Any wordAll words
Exact Phrase
Use keywords to find the product you are looking for.
Advanced Search
Bestsellers
01.Competitor Analysis: Erythropoietin (EPO)
02.Competitor Analysis: Anti-Obesity Peptides and Biologics
03.Competitor Analysis: IGF-1R Antagonists
04.Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors
05.Competitor Analysis: Coagulation Factors
Specials more

Psoriasis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
2,795  EUR
[$3,500.00 USD]

2,236  EUR
[$2,800.00 USD]
Newest Product more
Anesthesia Drugs Market (2011 - 2015) - U.S. Market Entry Study
3,713  EUR
[$4,650.00 USD]
La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie Publishing | Ulrich Martin | Mittelstrasse 11 | 70180 Stuttgart | Germany | T +49-1570-3544 127 | F +49-3212-1267 572 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L


Secure Websites